Table 1

Clinical and laboratory characteristics of surgical patients with ET and PV at diagnosis

CharacteristicPV, n = 105ET, n = 150P
Male/female, no./no. 66/39 62/88 .001* 
Age, y; median (range) 61 (28-85) 59 (20-84) .13 
Presence of at least 1 cardiovascular risk factor, no. (%) 62 (59) 66 (44) .02* 
Previous arterial thrombosis, no. (%) 14 (10.7) 22 (11.7) .79 
Previous venous thromboembolism, no. (%) 3 (2.8) 6 (4) .62 
Symptoms at presentation, no. (%)    
    None 72 (68.5) 107 (71.3) .36 
    Microvascular disturbances 28 (26.6) 33 (22.0) .45 
    Arterial thrombosis 2 (1.9) 6 (4.0) .47 
    Venous thromboembolism 1 (0.9) 3 (2) .64 
    Hemorrhage 2 (1.9) 1 (0.7) .57 
Hemoglobin level, g/L, mean plus or minus SD 180 ± 19.3 140 ± 14 <.001* 
Hematocrit level, %, mean plus or minus SD 55.1 ± 6.1 41.7 ± 3.6 <.001* 
Leukocyte, × 109/L, mean plus or minus SD 10.2 ± 4 10.2 ± 3.8 .90 
Platelet, × 109/L, mean plus or minus SD 516 ± 239 911 ± 376 <.001* 
CharacteristicPV, n = 105ET, n = 150P
Male/female, no./no. 66/39 62/88 .001* 
Age, y; median (range) 61 (28-85) 59 (20-84) .13 
Presence of at least 1 cardiovascular risk factor, no. (%) 62 (59) 66 (44) .02* 
Previous arterial thrombosis, no. (%) 14 (10.7) 22 (11.7) .79 
Previous venous thromboembolism, no. (%) 3 (2.8) 6 (4) .62 
Symptoms at presentation, no. (%)    
    None 72 (68.5) 107 (71.3) .36 
    Microvascular disturbances 28 (26.6) 33 (22.0) .45 
    Arterial thrombosis 2 (1.9) 6 (4.0) .47 
    Venous thromboembolism 1 (0.9) 3 (2) .64 
    Hemorrhage 2 (1.9) 1 (0.7) .57 
Hemoglobin level, g/L, mean plus or minus SD 180 ± 19.3 140 ± 14 <.001* 
Hematocrit level, %, mean plus or minus SD 55.1 ± 6.1 41.7 ± 3.6 <.001* 
Leukocyte, × 109/L, mean plus or minus SD 10.2 ± 4 10.2 ± 3.8 .90 
Platelet, × 109/L, mean plus or minus SD 516 ± 239 911 ± 376 <.001* 
*

indicates Mann-Whitney test was adopted to calculate P values of continuous variables.

Diabetes on treatment, hypercholesterolemia on treatment, arterial hypertension on treatment, previous AT, cardiovascular diseases (atrial fibrillation, valvular or coronary disease), or smoking.

or Create an Account

Close Modal
Close Modal